AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 1 filers reported holding AKARI THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $22,774 | +48355.3% | 134,046 | -48.7% | 0.00% | – |
| Q1 2023 | $47 | +74.1% | 261,192 | +374.2% | 0.00% | – |
| Q4 2022 | $27 | -99.9% | 55,081 | +46.7% | 0.00% | – |
| Q3 2022 | $24,000 | +71.4% | 37,544 | +162.9% | 0.00% | – |
| Q2 2022 | $14,000 | -44.0% | 14,281 | -6.5% | 0.00% | – |
| Q3 2021 | $25,000 | -57.6% | 15,276 | -43.6% | 0.00% | – |
| Q2 2020 | $59,000 | +37.2% | 27,097 | -1.1% | 0.00% | – |
| Q4 2018 | $43,000 | -38.6% | 27,409 | +0.4% | 0.00% | – |
| Q3 2018 | $70,000 | +1.4% | 27,296 | -22.8% | 0.00% | – |
| Q2 2018 | $69,000 | -77.8% | 35,343 | -79.3% | 0.00% | – |
| Q1 2018 | $311,000 | -72.4% | 170,622 | -34.4% | 0.00% | -100.0% |
| Q4 2017 | $1,126,000 | +58.8% | 260,020 | +125.0% | 0.00% | +100.0% |
| Q3 2017 | $709,000 | -28.2% | 115,543 | -46.0% | 0.00% | -50.0% |
| Q2 2017 | $987,000 | +32.8% | 214,126 | +318.0% | 0.00% | 0.0% |
| Q4 2015 | $743,000 | -50.0% | 51,221 | -17.3% | 0.00% | -33.3% |
| Q3 2015 | $1,486,000 | – | 61,942 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 7,941,867 | $1,443,037 | 1.26% |
| Omnia Family Wealth, LLC | 782,372 | $142,157 | 0.11% |
| NEA Management Company, LLC | 452,167 | $82,159 | 0.01% |
| Hikari Power Ltd | 130,821 | $24 | 0.00% |
| Bryn Mawr Capital Management, LLC | 100,000 | $18,170 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 30,264 | $5,495 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 261,192 | $47 | 0.00% |
| Renaissance Technologies | 283,550 | $52 | 0.00% |
| LPL Financial LLC | 134,453 | $24,430 | 0.00% |
| JPMORGAN CHASE & CO | 237 | $0 | 0.00% |